The recurrent mutation in TMEM106B also causes hypomyelinating leukodystrophy in China and is a CpG hotspot (English)
- New search for: Yan, H.
- New search for: Kubisiak, T.
- New search for: Ji, H.
- New search for: Xiao, J.
- New search for: Wang, J.
- New search for: Burmeister, M.
- New search for: Yan, H.
- New search for: Kubisiak, T.
- New search for: Ji, H.
- New search for: Xiao, J.
- New search for: Wang, J.
- New search for: Burmeister, M.
In:
BRAIN
;
141
, 5
;
e36-e36
;
2018
-
ISSN:
- Article (Journal) / Print
-
Title:The recurrent mutation in TMEM106B also causes hypomyelinating leukodystrophy in China and is a CpG hotspot
-
Contributors:Yan, H. ( author ) / Kubisiak, T. ( author ) / Ji, H. ( author ) / Xiao, J. ( author ) / Wang, J. ( author ) / Burmeister, M. ( author )
-
Published in:BRAIN ; 141, 5 ; e36-e36
-
Publisher:
- New search for: Oxford University Press
-
Publication date:2018-01-01
-
Size:e36-e36
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 616.8
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 616.8 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 141, Issue 5
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1235
-
EditorialKullmann, D. M. et al. | 2018
- 1236
-
The snowball effect of RNA binding protein dysfunction in amyotrophic lateral sclerosisFratta, P. / Isaacs, A. M. et al. | 2018
- 1239
-
Functional ‘unlocking’: bedside detection of covert awareness after severe brain damageBoly, M. / Laureys, S. et al. | 2018
- 1241
-
Is longitudinal tau PET ready for use in Alzheimer’s disease clinical trials?Hansson, O. / Mormino, E. C. et al. | 2018
- 1244
-
Disease progression models for dominantly-inherited Alzheimer’s diseaseLi, D. / Donohue, M. C. et al. | 2018
- 1247
-
Perturbed autophagy and DNA repair converge to promote neurodegeneration in amyotrophic lateral sclerosis and dementiaWalker, C. / El-Khamisy, S. F. et al. | 2018
- 1263
-
Neurotransmitter deficits from frontotemporal lobar degenerationMurley, A. G. / Rowe, J. B. et al. | 2018
- 1286
-
Mechanistic basis of an epistatic interaction reducing age at onset in hereditary spastic paraplegiaNewton, T. / Allison, R. / Edgar, J. R. / Lumb, J. H. / Rodger, C. E. / Manna, P. T. / Rizo, T. / Kohl, Z. / Nygren, A. O. / Arning, L. et al. | 2018
- 1300
-
Metastatic group 3 medulloblastoma is driven by PRUNE1 targeting NME1–TGF-β–OTX2–SNAIL via PTEN inhibitionFerrucci, V. / de Antonellis, P. / Pennino, F. P. / Asadzadeh, F. / Virgilio, A. / Montanaro, D. / Galeone, A. / Boffa, I. / Pisano, I. / Scognamiglio, I. et al. | 2018
- 1320
-
TDP-43 regulates the alternative splicing of hnRNP A1 to yield an aggregation-prone variant in amyotrophic lateral sclerosisDeshaies, J. E. / Shkreta, L. / Moszczynski, A. J. / Sidibé, H. / Semmler, S. / Fouillen, A. l. / Bennett, E. R. / Bekenstein, U. / Destroismaisons, L. / Toutant, J. et al. | 2018
- 1334
-
T helper 17.1 cells associate with multiple sclerosis disease activity: perspectives for early interventionvan Langelaar, J. / van der Vuurst de Vries, R. M. / Janssen, M. / Wierenga-Wolf, A. F. / Spilt, I. M. / Siepman, T. A. / Dankers, W. / Verjans, G. M. / de Vries, H. E. / Lubberts, E. et al. | 2018
- 1350
-
Protein instability, haploinsufficiency, and cortical hyper-excitability underlie STXBP1 encephalopathyKovačević, J. / Maroteaux, G. / Schut, D. / Loos, M. / Dubey, M. / Pitsch, J. / Remmelink, E. / Koopmans, B. / Crowley, J. / Cornelisse, L. N. et al. | 2018
- 1375
-
Disrupted dynamic network reconfiguration of the language system in temporal lobe epilepsyHe, X. / Bassett, D. S. / Chaitanya, G. / Sperling, M. R. / Kozlowski, L. / Tracy, J. I. et al. | 2018
- 1390
-
KEAP1 inhibition is neuroprotective and suppresses the development of epilepsyShekh-Ahmad, T. / Eckel, R. / Dayalan Naidu, S. / Higgins, M. / Yamamoto, M. / Dinkova-Kostova, A. T. / Kovac, S. / Abramov, A. Y. / Walker, M. C. et al. | 2018
- 1404
-
Characterization of EEG signals revealing covert cognition in the injured brainCurley, W. H. / Forgacs, P. B. / Voss, H. U. / Conte, M. M. / Schiff, N. D. et al. | 2018
- 1422
-
Artificial limb representation in amputeesvan den Heiligenberg, F. M. / Orlov, T. / Macdonald, S. N. / Duff, E. P. / Henderson Slater, D. / Beckmann, C. F. / Johansen-Berg, H. / Culham, J. C. / Makin, T. R. et al. | 2018
- 1434
-
The striatal kinase DCLK3 produces neuroprotection against mutant huntingtinGalvan, L. / Francelle, L. / Gaillard, M. C. / de Longprez, L. / Carrillo-de Sauvage, M. A. / Liot, G. r. / Cambon, K. / Stimmer, L. / Luccantoni, S. / Flament, J. et al. | 2018
- 1455
-
Distinct effects of apathy and dopamine on effort-based decision-making in Parkinson’s diseaseLe Heron, C. / Plant, O. / Manohar, S. / Ang, Y. S. / Jackson, M. / Lennox, G. / Hu, M. T. / Husain, M. et al. | 2018
- 1470
-
Electromagnetic signatures of the preclinical and prodromal stages of Alzheimer’s diseaseNakamura, A. / Cuesta, P. / Fernández, A. / Arahata, Y. / Iwata, K. / Kuratsubo, I. / Bundo, M. / Hattori, H. / Sakurai, T. / Fukuda, K. et al. | 2018
- 1486
-
Preferential degradation of cognitive networks differentiates Alzheimer’s disease from ageingChhatwal, J. P. / Schultz, A. P. / Johnson, K. A. / Hedden, T. / Jaimes, S. / Benzinger, T. L. / Jack, C. / Ances, B. M. / Ringman, J. M. / Marcus, D. S. et al. | 2018
- 1501
-
Nucleus basalis of Meynert degeneration precedes and predicts cognitive impairment in Parkinson’s diseaseSchulz, J. / Pagano, G. / Fernández Bonfante, J. A. / Wilson, H. / Politis, M. et al. | 2018
- 1517
-
Longitudinal tau PET in ageing and Alzheimer’s diseaseJack, C. R. / Wiste, H. J. / Schwarz, C. G. / Lowe, V. J. / Senjem, M. L. / Vemuri, P. / Weigand, S. D. / Therneau, T. M. / Knopman, D. S. / Gunter, J. L. et al. | 2018
- 1529
-
Data-driven models of dominantly-inherited Alzheimer’s disease progressionOxtoby, N. P. / Young, A. L. / Cash, D. M. / Benzinger, T. L. / Fagan, A. M. / Morris, J. C. / Bateman, R. J. / Fox, N. C. / Schott, J. M. / Alexander, D. C. et al. | 2018
- 1545
-
A neurocomputational account of reward and novelty processing and effects of psychostimulants in attention deficit hyperactivity disorderSethi, A. / Voon, V. / Critchley, H. D. / Cercignani, M. / Harrison, N. A. et al. | 2018
- 1558
-
Altruistic decisions following penetrating traumatic brain injuryMoll, J. / de Oliveira-Souza, R. / Basilio, R. / Bramati, I. E. / Gordon, B. / Rodríguez-Nieto, G. / Zahn, R. / Krueger, F. / Grafman, J. et al. | 2018
- 1570
-
How the coming of the NHS changed British neurologyShorvon, S. et al. | 2018
- e36
-
The recurrent mutation in TMEM106B also causes hypomyelinating leukodystrophy in China and is a CpG hotspotYan, H. / Kubisiak, T. / Ji, H. / Xiao, J. / Wang, J. / Burmeister, M. et al. | 2018
- e37
-
Reply: The recurrent mutation in TMEM106B also causes hypomyelinating leukodystrophy in China and is a CpG hotspotSimons, C. / Dyment, D. / van der Knaap, M. S. / Wolf, N. I. et al. | 2018
- e38
-
Towards personalized therapy for multiple sclerosis: limitations of observational dataSteyerberg, E. W. / Claggett, B. et al. | 2018
- e39
-
Reply: Towards personalized therapy for multiple sclerosis: limitations of observational dataKalincik, T. et al. | 2018
- e40
-
Noisy but not placebo: defining metrics for effects of neurofeedbackWitte, M. / Kober, S. E. / Wood, G. et al. | 2018
- e41
-
Reply: Noisy but not placebo: defining metrics for effects of neurofeedbackSchabus, M. et al. | 2018
- e42
-
Corrigendum| 2018